Skip to main content

Animations

MJFF Publications

5571 - 5580 of 8801 Results
Title
Year
  • Year
  • 2017
  • 2019
  • 2019
  • 2019
  • 2018
  • 2019
  • 2019
  • 2025
  • 2008
  • 2009
  • Summary Details
    OPEN
    Title: Neuropathological and transcriptomic characteristics of the aged brain
    Journal Name: eLife
    Publisher: eLife Sciences Publications, Ltd
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.7554/elife.31126
    Citation Count: 127
  • Summary Details
    OPEN
    Title: Common BACE2 Polymorphisms are Associated with Altered Risk for Alzheimer’s Disease and CSF Amyloid Biomarkers in APOE ε4 Non-Carriers
    Journal Name: Scientific Reports
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41598-019-45896-4
    Citation Count: 21
  • Summary Details
    OPEN
    Title: The Personalized Parkinson Project: examining disease progression through broad biomarkers in early Parkinson’s disease
    Journal Name: BMC Neurology
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1186/s12883-019-1394-3
    Citation Count: 112
  • Summary Details
    OPEN
    Title: Parkinson's Disease Detection Using Isosurfaces-Based Features and Convolutional Neural Networks
    Journal Name: Frontiers in Neuroinformatics
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fninf.2019.00048
    Citation Count: 86
  • Summary Details
    OPEN
    Title: Identification of evolutionarily conserved gene networks mediating neurodegenerative dementia
    Journal Name: Nature Medicine
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1038/s41591-018-0223-3
    Citation Count: 135
  • Summary Details
    OPEN
    Title: End-of-life experiences in dementia with Lewy bodies: Qualitative interviews with former caregivers
    Journal Name: PLOS ONE
    Publisher: Public Library of Science (PLoS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1371/journal.pone.0217039
    Citation Count: 36
  • Summary Details
    OPEN
    Title: Mitochondria function associated genes contribute to Parkinson’s Disease risk and later age at onset
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41531-019-0080-x
    Citation Count: 126
  • Summary Details
    OPEN
    Title: Type II kinase inhibitors that target Parkinson’s disease–associated LRRK2
    Journal Name: Science Advances
    Publisher: American Association for the Advancement of Science (AAAS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1126/sciadv.adt2050
    Citation Count: 0
  • Summary Details
    OPEN
    Title: UCP2 mediates ghrelin’s action on NPY/AgRP neurons by lowering free radicals
    Journal Name: Nature
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: 1
    DOI - Digital Object Identifier: 10.1038/nature07181
    Citation Count: 685
  • Summary Details
    OPEN
    Title: Compounds from an unbiased chemical screen reverse both ER-to-Golgi trafficking defects and mitochondrial dysfunction in Parkinson’s disease models
    Journal Name: Disease Models & Mechanisms
    Publisher: The Company of Biologists
    Publication Date:
    Open Access(OA) Status: OPEN
    License: 1
    DOI - Digital Object Identifier: 10.1242/dmm.004267
    Citation Count: 178
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.